V-Bio Fund 2
The computed 12-month bankruptcy probability of V-Bio Fund 2 is 1.9% (moderate). The 2024 annual accounts show equity of €27.68M and a net result of €-2.16M. Equity is growing by ~45.4% per year across the filed fiscal years. The company has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €27.68M |
| Net result | €-2.16M |
| Active | 5 yrs |
| Locations | 1 |
Mixed profile: strong on stability, weaker on profitability.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
The full score breakdown, per-year score history and the indicative credit limit are in Kantoor S.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
Show 7 other metrics
| Fiscal year | 2024 |
|---|---|
| Deposit | verkort |
| Revenue | - |
| EBITDA | €-2.13M |
| Net profit | €-2.16M |
| Cash flow | €-2.12M |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €28.21M |
| Equity | €27.68M |
| Debt | €532k |
| of which ≤ 1y | €532k |
| of which > 1y | - |
| Working capital | €-376k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 0.29 |
| Quick ratio | 0.29 |
| Working capital ratio | -1.3% |
| Solvency | 98.1% |
| Debt / equity | 0.02 |
| Long-term debt ratio | - |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | -7.6% |
| ROE | -7.8% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
Full annual accounts (20 line items)
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €28.21M |
| Fixed assets | 21/28 | €28.01M |
| Formation expenses | 20 | €42k |
| Financial fixed assets | 28 | €28.01M |
| Current assets | 29/58 | €157k |
| Amounts receivable within one year | 40/41 | €10k |
| Cash & bank | 54/58 | €147k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €28.21M |
| Equity | 10/15 | €27.68M |
| Contributions / capital | 10/11 | €38.18M |
| Accumulated profits (losses) | 14 | €-10.50M |
| Amounts payable | 17/49 | €532k |
| Amounts payable within one year | 42/48 | €532k |
| Trade debts payable within one year | 44 | €532k |
| Income statement | ||
| Gross operating margin | 9900 | €-2.13M |
| Operating result | 9901 | €-2.17M |
| Financial income | 75 | €10k |
| Result before taxes | 9903 | €-2.16M |
| Net result for the period | 9904 | €-2.16M |
| Result to be appropriated | 9905 | €-2.16M |
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISESCurrent Company auditor · represented by Veerle Catry |
- | 14-12-2020 → present |
| NACE primary | - |
| Legal form | Public limited company(014) |
| Incorporation | 11-12-2020 |
| Status | Active |
| Postal code | 9051 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44062B0298/00V002 | Flanders | 2,297 m² | 1 · 810 m² | 13.1 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
We know of 9 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
20-04-2026 Act object · General meeting · Auditor waiver · Capital increase
- Filing: 2026-04-16 · V-Bio Fund 2
- Publication: 2026-04-20 · V-Bio Fund 2
- Act object: KAPITAAL, AANDELEN, STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN) · V-Bio Fund 2
- General meeting: 2026-04-08 · V-Bio Fund 2
- Auditor waiver · V-Bio Fund 2
- Capital increase: share_type: Soort A, shares_issued: 22000000, paid_up_percentage: 40 · V-Bio Fund 2
- Statute amendment: article: 5, new_text: Artikel 5. KAPITAAL. Het kapitaal bedraagt achtentachtig miljoen honderdduizend euro (€ 88.100.000,00). Het wordt vertegenwoordigd door achtentachtig miljoen (88.000.000) Soort A Aandelen (“Soort A Aandelen”) en honderdduizend (100.000) Soort B Aandelen (“Soort B Aandelen”), zonder vermelding van waarde, die ieder een gelijk deel van het kapitaal vertegenwoordigen. De enige bestuurder kan verzoeken om de gehele of gedeeltelijke volstorting van bepaalde aandelen zonder dat het vereist is dat gelijktijdig voor hetzelfde bedrag wordt verzocht om volstorting van alle aandelen, weze het van dezelfde of een andere soort. · V-Bio Fund 2
- Power of attorney: purpose: coördinatie, granted_to: bestuursorgaan · V-Bio Fund 2
- Notarial deed: 2026-04-08 · V-Bio Fund 2
Technical details
{
"facts": [
{
"type": "filing",
"quote": "Neergelegd 16-04-2026",
"value": "2026-04-16",
"object": null,
"subject": "e1"
},
{
"type": "publication",
"quote": "Bijlagen bij het Belgisch Staatsblad - 20/04/2026",
"value": "2026-04-20",
"object": null,
"subject": "e1"
},
{
"type": "act_object",
"quote": "Onderwerp akte : KAPITAAL, AANDELEN, STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN)",
"value": "KAPITAAL, AANDELEN, STATUTEN (VERTALING, COORDINATIE, OVERIGE WIJZIGINGEN)",
"object": null,
"subject": "e1"
},
{
"type": "general_meeting",
"quote": "Op heden, acht april tweeduizend zesentwintig.",
"value": "2026-04-08",
"object": null,
"subject": "e1"
},
{
"type": "auditor_waiver",
"quote": "EERSTE BESLISSING: Verzaking aan het opstellen van de uitgifteverslaggeving.",
"value": null,
"object": null,
"subject": "e1"
},
{
"type": "capital_increase",
"quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 22.000.000,00 EUR, om het van 66.100.000,00 EUR te brengen op 88.100.000,00 EUR, door inbreng in geld en met de uitgifte van 22.000.000 Soort A aandelen... tegen de prijs van 1,00 EUR elk en dat op ieder aandeel onmiddellijk gestort zal worden ten belope van 40%... gestort is ten belope van 40%. De kapitaalverhoging is bijgevolg volgestort ten belope van 8.800.000,00 EUR.",
"value": {
"delta": {
"amount": 22000000.0,
"currency": "EUR"
},
"share_type": "Soort A",
"issue_price": {
"amount": 1.0,
"currency": "EUR"
},
"amount_after": {
"amount": 88100000.0,
"currency": "EUR"
},
"amount_before": {
"amount": 66100000.0,
"currency": "EUR"
},
"shares_issued": 22000000,
"paid_up_amount": {
"amount": 8800000.0,
"currency": "EUR"
},
"paid_up_percentage": 40
},
"object": null,
"subject": "e1"
},
{
"type": "statute_amendment",
"quote": "ZEVENDE BESLISSING: Wijziging van de statuten. Teneinde de statuten in overeenstemming te brengen met de beslissing tot kapitaalverhoging die voorafgaat, beslist de vergadering artikel 5 van de statuten te vervangen door de volgende tekst : \u0022Artikel 5. KAPITAAL. Het kapitaal bedraagt achtentachtig miljoen honderdduizend euro (\u20AC 88.100.000,00). Het wordt vertegenwoordigd door achtentachtig miljoen (88.000.000) Soort A Aandelen (\u201CSoort A Aandelen\u201D) en honderdduizend (100.000) Soort B Aandelen (\u201CSoort B Aandelen\u201D), zonder vermelding van waarde, die ieder een gelijk deel van het kapitaal vertegenwoordigen. De enige bestuurder kan verzoeken om de gehele of gedeeltelijke volstorting van bepaalde aandelen zonder dat het vereist is dat gelijktijdig voor hetzelfde bedrag wordt verzocht om volstorting van alle aandelen, weze het van dezelfde of een andere soort.\u0022.",
"value": {
"article": 5,
"new_text": "Artikel 5. KAPITAAL. Het kapitaal bedraagt achtentachtig miljoen honderdduizend euro (\u20AC 88.100.000,00). Het wordt vertegenwoordigd door achtentachtig miljoen (88.000.000) Soort A Aandelen (\u201CSoort A Aandelen\u201D) en honderdduizend (100.000) Soort B Aandelen (\u201CSoort B Aandelen\u201D), zonder vermelding van waarde, die ieder een gelijk deel van het kapitaal vertegenwoordigen. De enige bestuurder kan verzoeken om de gehele of gedeeltelijke volstorting van bepaalde aandelen zonder dat het vereist is dat gelijktijdig voor hetzelfde bedrag wordt verzocht om volstorting van alle aandelen, weze het van dezelfde of een andere soort."
},
"object": null,
"subject": "e1"
},
{
"type": "power_of_attorney",
"quote": "ACHTSTE BESLISSING: Volmacht voor de co\u00F6rdinatie.",
"value": {
"purpose": "co\u00F6rdinatie",
"granted_to": "bestuursorgaan"
},
"object": null,
"subject": "e1"
},
{
"type": "notarial_deed",
"quote": "Op heden, acht april tweeduizend zesentwintig.",
"value": "2026-04-08",
"object": null,
"subject": "e1"
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 4524,
"truncated": false,
"needs_verify": false
},
"entities": [
{
"id": "e1",
"kbo": "0759.685.291",
"kind": "company",
"name": "V-Bio Fund 2",
"attrs": {
"seat": "Pieter van Reysschootlaan 2 bus 104, 9051 Gent",
"legal_form": "Naamloze vennootschap"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Yorik DESMYTTERE",
"attrs": {
"firm": "BERQUIN NOTARISSEN",
"role": "notaris",
"firm_seat": "1000 Brussel, Lloyd Georgelaan 11"
}
}
]
}15-04-2025 Articles of association amended
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2025-04-10",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0759.685.291",
"name_full": "V-BIO FUND 2",
"legal_form": "NV"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}13-11-2023 Capital increase of €22,000,000 to €44,100,000
- €22.100.000 → €44.100.000
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 22000000.0,
"currency": "EUR",
"after_eur": 44100000.0,
"delta_eur": 22000000.0,
"before_eur": 22100000.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-10-31",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 22.000.000,00 EUR, om het van 22.100.000,00 EUR te brengen op 44.100.000,00 EUR, door inbreng in geld",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0759.685.291",
"name_full": "V-BIO FUND 2",
"legal_form": "NV"
}
}28-03-2022 Capital increase of €2,800,000 to €22,100,000
- €19.300.000 → €22.100.000
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 2800000.0,
"currency": "EUR",
"after_eur": 22100000.0,
"delta_eur": 2800000.0,
"before_eur": 19300000.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-03-18",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 2.800.000,00 EUR, om het van 19.300.000,00 EUR te brengen op 22.100.000,00 EUR, door inbreng in geld",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0759.685.291",
"name_full": "V-BIO FUND 2",
"legal_form": "NV"
}
}28-01-2022 Capital increase of €2,400,000 to €19,300,000
- €16.900.000 → €19.300.000
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 2400000.0,
"currency": "EUR",
"after_eur": 19300000.0,
"delta_eur": 2400000.0,
"before_eur": 16900000.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-01-21",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 2.400.000,00 EUR, om het van 16.900.000,00 EUR te brengen op 19.300.000,00 EUR, door inbreng in geld",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0759.685.291",
"name_full": "V-BIO FUND 2",
"legal_form": "NV"
}
}15-10-2021 Capital increase of €1,203,400 to €16,900,000
- €15.696.600 → €16.900.000
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 1203400.0,
"currency": "EUR",
"after_eur": 16900000.0,
"delta_eur": 1203400.0,
"before_eur": 15696600.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2011-09-24",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 1.203.400,00 EUR, om het van 15.696.600,00 EUR te brengen op 16.900.000,00 EUR, door inbreng in geld",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0759.685.291",
"name_full": "V-BIO FUND 2",
"legal_form": "NV"
}
}10-02-2021 Capital increase of €1,206,600 to €15,696,600
- €14.490.000 → €15.696.600
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 1206600.0,
"currency": "EUR",
"after_eur": 15696600.0,
"delta_eur": 1206600.0,
"before_eur": 14490000.0,
"amount_type": "kapitaal_effectief",
"effective_date": "2021-02-03",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 1.206.600,00 EUR, om het van 14.490.000,00 EUR te brengen op 15.696.600,00 EUR, door inbreng in geld",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0759.685.291",
"name_full": "V-BIO FUND 2",
"legal_form": "NV"
}
}18-12-2020 Capital increase of €14,200,000 to €14,490,000
- €290.000 → €14.490.000
Technical details
{
"events": [
{
"kind": "capital_increase",
"amount": 14200000,
"currency": "EUR",
"after_eur": 14490000,
"delta_eur": 14200000,
"before_eur": 290000,
"amount_type": "kapitaal_effectief",
"effective_date": "2020-12-14",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van veertien miljoen tweehonderdduizend euro (\u20AC14.200.000,00), om het van tweehonderdnegentigduizend euro (\u20AC290.000,00) te brengen op veertien miljoen vierhonderdnegentigduizend euro (\u20AC14.490.000,00), door inbreng in geld",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0759.685.291",
"name_full": "V-BIO FUND 2",
"legal_form": "NV"
}
}15-12-2020 Incorporation of a new NV
Technical details
{
"kind": "oprichting",
"seat": "Pieter van Reysschootlaan 2 bus 104, 9051 Gent",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "TAKKE Christina",
"niss": null,
"address": "Feike de Boerlaan 14, 1019MN Amsterdam (Nederland)"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 57000,
"holder_person_name": "TAKKE Christina",
"is_subscriber_only": false,
"n_shares_subscribed": 57000,
"amount_subscribed_eur": 57000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "BROEKAERT Willem Frans",
"niss": null,
"address": "Kluizenbosweg 1, 1700 Dilbeek"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 57000,
"holder_person_name": "BROEKAERT Willem Frans",
"is_subscriber_only": false,
"n_shares_subscribed": 57000,
"amount_subscribed_eur": 57000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "MARGETSON Shelley",
"niss": null,
"address": "Hofvliet 91, 2251TJ Voorschoten (Nederland)"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 57000,
"holder_person_name": "MARGETSON Shelley",
"is_subscriber_only": false,
"n_shares_subscribed": 57000,
"amount_subscribed_eur": 57000,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": null,
"name": "ROSENKRANZ Katja",
"niss": null,
"address": "Gezondheidstraat 31, 9000 Gent"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 19000,
"holder_person_name": "ROSENKRANZ Katja",
"is_subscriber_only": false,
"n_shares_subscribed": 19000,
"amount_subscribed_eur": 19000,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": "0758.543.661",
"name": "V-BIO PARTNERS 2"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "B",
"partner_role": null,
"holder_org_kbo": "0758.543.661",
"holder_org_name": "V-BIO PARTNERS 2",
"contribution_type": "cash",
"amount_paid_in_eur": 100000,
"holder_person_name": null,
"is_subscriber_only": false,
"n_shares_subscribed": 100000,
"amount_subscribed_eur": 100000,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 290000,
"subject_company": {
"kbo": "0759.685.291",
"name_full": "V-Bio Fund 2",
"legal_form": "NV"
},
"initial_directors": [],
"incorporation_date": "2020-12-11",
"post_incorporation_mandates": []
}| Legal nameNL | V-Bio Fund 2 |